Associate Director – Research
Dr. Volker Gerdts received a DVM in 1994 from Hanover Veterinary School and a German PhD equivalent from the Federal Research Institute for Animal Health, Island of Riems and Hanover Veterinary School, Germany, in 1997. A postdoctoral fellowship, funded by the German Research Council, was spent from 1998-2000 at VIDO-InterVac in the area of vaccine discovery and mucosal immunology. In 2002, he became a Research Scientist at VIDO-InterVac and the Associate Director of Research in 2007.
Dr. Gerdts research interests are in the area of neonatal vaccines for both humans and animals, mucosal immunology, and vaccine delivery and formulation. Current research projects are focused on vaccine development for Porcine Reproductive and Respiratory Syndrome Virus, adjuvants, porcine immunology and the use of pigs as model for humans, immune modulation and regulation of mucosal immune responses.
- Neonatal vaccines for humans and animals
- Mucosal immunology
- Vaccine delivery and formulation
- African Swine Fever vaccine development
- Chlamydia trachomatis – animal model and vaccine development
- Development of a vaccine for contagious bovine pleuropneumonia
- Development of novel combination adjuvants
- Johne’s disease in cattle – pathogenesis and control of Mycobacterium avium subspecies paratuberculosis
- Pathogenesis and vaccine development for Porcine Reproductive and Respiratory Syndrome
- Pertussis - development of a neonatal pertussis vaccine
- Vaccine development for bacterial diseases of pigs – Streptococcus suis, Bordetella bronchiseptica, Actinobacillus pleuropneumoniae
- Vaccine development for porcine epidemic diarrhea virus